This listing is for SGT-280 in powder form.
SGT 280 (Cumyl-CBMICA) is a newly studied synthetic cannabinoid. It was first discovered in August 2019 and later defined in 2020 as a new psychoactive substance (NPS). It has been studied as a synthetic cannabinoid receptor (SCRA) agonist, but contradicts the definition of the discovery because SGT 280 has a unique side chain. Above the side chain, it closely mimics the SCRA Cumyl-PICA.